Nath Bio-Genes (India) Limited
Simbol: NATHBIOGEN.NS
NSE
195
INRTržna cena danes
9.0886
Razmerje P/E
2.0302
Razmerje PEG
3.71B
Kapaciteta MRK
- 0.02%
Donos DIV
Nath Bio-Genes (India) Limited (NATHBIOGEN-NS) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2089.2 | 41.7 | 292.1 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 1709.3 | 0.2 | 0 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1033.6 | 2456.6 | 2683.8 | ||||||||||||
balance-sheet.row.inventory | 0 | 2078.5 | 2203.4 | 2263 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 7 | 0 | 0 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 5208.3 | 4701.7 | 5238.9 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2339.6 | 2328.5 | 2333 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 50.5 | 50.5 | 50.5 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 218.1 | 136.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 225.4 | 0 | 0 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2719.7 | 2717.4 | 2656.2 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.account-payables | 0 | 277.4 | 550.9 | 452.3 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1048.1 | 922.9 | 959.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 2.8 | 8.9 | 25.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 6.6 | 6.5 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 830.4 | 63.6 | 0 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 31.7 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-liab | 0 | 2196.2 | 1999.4 | 1762.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 190 | 190 | 190 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 4056.6 | 3744.7 | 4456.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 150.1 | 149.9 | 151.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1335 | 1335 | 1335 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5731.7 | 5419.7 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.minority-interest | 0 | -0.2 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 5731.5 | 5419.6 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 50.5 | 50.6 | 50.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1052.1 | 929.6 | 965.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | 672.2 | 887.9 | 673.6 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 361.6 | -633.9 | 567.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 30.1 | 30.8 | 28.2 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -98.1 | -180.7 | -651.3 | |||||||||||
cash-flows.row.account-receivables | 0 | -118.8 | 210.2 | -20.6 | |||||||||||
cash-flows.row.inventory | 0 | 125 | 59.6 | -219.9 | |||||||||||
cash-flows.row.account-payables | 0 | -150.5 | 199.9 | -229.7 | |||||||||||
cash-flows.row.other-working-capital | 0 | 46.2 | -650.4 | -181.1 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 90 | 954.2 | 66.7 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0.5 | 0.7 | 1.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.2 | -0.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -0.5 | -0.7 | -1.5 | |||||||||||
cash-flows.row.other-investing-activites | 0 | -3.4 | 11.7 | 13.7 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -28.8 | -198.7 | -102.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -122.5 | -78.2 | -252.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | -38 | -38 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 143.9 | -106.1 | 416.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -16.7 | -222.3 | 164 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.1 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 338.1 | -250.5 | 72.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 380 | 41.7 | 292.2 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 41.8 | 292.2 | 219.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 383.7 | 170.5 | 11.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 358.2 | -39.7 | -104.9 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3326.2 | 3012.9 | 2783.6 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1650.8 | 1345.9 | 1239.7 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 1675.4 | 1667 | 1543.9 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 1209.4 | 1208.2 | 1197.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2860.2 | 2554.1 | 2437 | |||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 10.9 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 32.6 | 30.1 | 30.8 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 466 | 457.3 | 345.7 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 381.2 | 363.2 | -633.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 19.5 | 11.5 | 39.5 | |||||||||||||
income-statement-row.row.net-income | 0 | 361.7 | 350.1 | -673.4 |
Pogosto zastavljeno vprašanje
Kaj je Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) skupna sredstva?
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) skupna sredstva so 7927970000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.528.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 3.442.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.121.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.147.
Kaj je Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 361697000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 1052123000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 1209402000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.